Parinaud oculoglandular syndrome is an eye problem that is similar to conjunctivitis ("pink eye"). It most often affects only one eye. It occurs with swollen lymph nodes and an illness with a fever.
Note: Parinaud syndrome (also called upgaze paresis) is a different disorder in which you have trouble looking upward. This can be caused by a brain tumor, and requires an immediate evaluation by your health care provider.
Parinaud oculoglandular syndrome (POS) is caused by an infection with bacteria, a virus, fungus, or parasite.
The most common causes are cat scratch disease and tularemia (rabbit fever). The bacteria that cause either condition can infect the eye. The bacteria can directly enter the eye (on a finger or other object), or air droplets that carry the bacteria can land on the eye.
Other infectious diseases may spread the same way, or through the bloodstream to the eye.
An exam shows:
Blood tests will be done to check for infection. The white blood cell count may be high or low, depending on the cause of the infection.
A blood test to check antibody levels is the main method used to diagnose many of the infections that cause POS. Other tests may include:
Depending on the cause of the infection, antibiotics may be helpful. Surgery may be needed in rare cases to clean away the infected tissues.
The outlook depends on the cause of the infection. In general, if the diagnosis is made early and treatment starts right away, the outcome of POS can be very good.
Serious complications are rare.
The conjunctival nodules can sometimes form sores (ulcers) during the healing process. The infection can spread to nearby tissues or into the bloodstream.
You should call your provider if you develop a red, irritated, painful eye.
Frequent hand washing can reduce the likelihood of getting POS. Avoid being scratched by a cat, even a healthy cat. You can avoid tularemia by not having contact with wild rabbits, squirrels, or ticks.
Reviewed By: Franklin W. Lusby, MD, ophthalmologist, Lusby Vision Institute, La Jolla, CA. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.